DLDRX | DNLAX | DLDRX / DNLAX | |
Total Expense Ratio | 0.89 | 1.16 | 77% |
Annual Report Gross Expense Ratio | 0.75 | 1.16 | 65% |
Fund Existence | 21 years | 21 years | - |
Gain YTD | -20.251 | -20.300 | 100% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 1000 | 1000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 927M | 927M | 100% |
Annual Yield % from dividends | 1.48 | 1.22 | 121% |
Returns for 1 year | -32.77 | -32.96 | 99% |
Returns for 3 years | -39.95 | -40.58 | 98% |
Returns for 5 years | 66.49 | 63.78 | 104% |
Returns for 10 years | 20.69 | 18.30 | 113% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
DFAX | 23.37 | -0.18 | -0.76% |
Dimensional World ex US Core Eq 2 ETF | |||
FSEP | 41.22 | -0.49 | -1.17% |
FT Vest US Equity Buffer ETF Sep | |||
SIXS | 41.97 | -1.17 | -2.71% |
ETC 6 Meridian Small Cap Equity ETF | |||
MVT | 9.96 | -0.43 | -4.14% |
Blackrock Munivest Fund II | |||
BBP | 50.54 | -2.24 | -4.25% |
Virtus LifeSci Biotech Products ETF |